No significant difference was observed in five neuropeptides (α‐MSH, β‐endorphin, neurotensin, oxytocin, and substance P) in patients with schizophrenia, BD, or MDD compared with healthy controls (Figure 1). This evidence concerns the gene OXT and Behcet disease.